The STAT4/MLL1 Epigenetic Axis Regulates the Antimicrobial Functions of Murine Macrophages

William F Carson1, Karen A Cavassani2, Elyara M Soares3

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109; slkunkel@umich.edu.

Insights

The histone methyltransferase mixed-lineage leukemia 1 (MLL1) regulates macrophage inflammation. MLL1 deficiency enhances macrophage antimicrobial functions by altering epigenetic modifications.

Area of Science:

  • Immunology
  • Epigenetics
  • Cell Biology

Background:

  • Macrophages are key immune cells involved in pathogen clearance and tissue homeostasis.
  • Macrophage inflammatory responses are regulated by gene expression, often controlled by epigenetic mechanisms like histone methylation.
  • The histone methyltransferase mixed-lineage leukemia 1 (MLL1) plays a role in regulating gene accessibility and macrophage polarization.

Purpose of the Study:

  • To investigate the role of MLL1 in mediating macrophage inflammatory responses.
  • To understand how MLL1 influences macrophage antimicrobial functions through epigenetic regulation.

Main Methods:

  • Utilized bone marrow-derived macrophages from MLL1 gene knockout mice (Lys2-Cre+/- MLL1(fx/fx)).
  • Assessed gene expression, histone methylation patterns, and phagocytic/bacterial killing activity.
  • Performed RNA profiling to identify altered gene expression in MLL1-deficient macrophages.

Main Results:

  • MLL1 deficiency led to decreased proinflammatory gene expression and reduced activating histone methylation.
  • MLL1-knockout macrophages displayed enhanced phagocytic and bacterial killing activity in vitro.
  • RNA profiling revealed altered expression of inflammatory genes, including STAT4, in MLL1-deficient macrophages.
  • Type I IFNs, driven by STAT4, influenced MLL1 expression, and MLL1 knockout reduced histone methylation at the STAT4 promoter.

Conclusions:

  • MLL1 plays a critical role in regulating macrophage inflammatory responses.
  • MLL1-dependent epigenetic modifications are crucial for controlling macrophage antimicrobial functions.
  • Targeting MLL1 may offer therapeutic strategies for modulating macrophage activity in infectious diseases.